BioByte 098: big challenges in protein-design, OpenAI takes clinical trials, how non-neural cells remember and predicting psychiatric disease from social media.

BioByte 097: Drivers of biological progress, immunogenicity in gene therapy & a vision for AI scientists

BioByte 096: brain shuttles for antibody delivery, immune privilege in the brain, DNA data storage, clinical translation of spatial biology

BioByte 095: Using autrotrophs for food production, the future of computational drug discovery, calls for a CRISPR revolution, a proteogenomic pipeline for neoantigen discovery

BioByte 094: industry consortium for benchmarking, evaluating protein competitions, multimodal atlas for Alzheimer's, automated organelle tracking, promise of a new HAE treatment

BioByte 093: A big week for AI, GLP-1s program the neurovascular landscape , an AAV primer and LLCs in biotech

BioByte 092: reversing diabetes with cell therapy, the effect of mislocalization of proteins within a cell, DNA methylation in the brain, NIH-wide exposome research centre launch

BioByte 091: quantum biology, a foundation model for drug repurposing, functional genomic variant interpretation, and new mechanisms in brain metabolism

BioByte 090: LLMs for novel research, the chemistry synthesis bottleneck, on the origin of viruses, molecular de-extinction, and targeted protein relocalization

BioByte 089: ten commandments of drug R&D, a foundation model for CGMs, expanding the genetic code without modifying the genome

It's our second birthday. Help us improve!

BioByte 088: AlphaProteo, Merck's Blockbuster Recipe, Dark Genome and Grand Challenges in Healthcare